JPRN-jRCT1080224091
Recruiting
未知
Investigation of the safety and efficacy of Budesonide ( Zentacort Capsules ) in patients with Crohn's disease
ConditionsCrohn's disease
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Crohn's disease
- Sponsor
- ZERIA Pharmaceutical Co., Ltd.
- Enrollment
- 200
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •mild to moderate active Crohn's disease in patients
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
A 12-Week study to find out if the effect of Budesonide/Formoterol SPIROMAX® is at least the same as of SYMBICORT TURBOHALER® and is safe and effective to treat children, teenagers, and adults with asthma.Persistent AsthmaMedDRA version: 14.1Level: PTClassification code 10003553Term: AsthmaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersTherapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]EUCTR2013-000081-11-BETeva Branded Pharmaceutical Products R&D, Inc.671
Active, not recruiting
Not Applicable
A 12-Week study to find out if the effect of Budesonide/Formoterol SPIROMAX® is at least the same as of SYMBICORT TURBOHALER® and is safe and effective to treat children, teenagers, and adults with asthma.Persistent AsthmaMedDRA version: 14.1Level: PTClassification code 10003553Term: AsthmaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersTherapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]EUCTR2013-000081-11-FITeva Branded Pharmaceutical Products R&D, Inc.600
Completed
Phase 3
A 12-Week Efficacy and Safety Evaluation of Budesonide/Formoterol SPIROMAX® 160/4.5 mcg Inhalation Powder Versus SYMBICORT® TURBOHALER® 200/6 mcg in Adult and Adolescent Patients with Persistent Asthma.chronical illness of the central nerve systemmultiple sclerosis10029305NL-OMON38727TEVA Pharma12
Active, not recruiting
Not Applicable
A 12-Week study to find out if the effect of Budesonide/Formoterol SPIROMAX® is at least the same as of SYMBICORT TURBOHALER® and is safe and effective to treat children, teenagers, and adults with asthma.Persistent AsthmaMedDRA version: 16.1Level: PTClassification code 10003553Term: AsthmaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersTherapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]EUCTR2013-000081-11-DKTeva Branded Pharmaceutical Products R&D, Inc.600
Active, not recruiting
Not Applicable
A 12-Week study to find out if the effect of Budesonide/Formoterol SPIROMAX® is at least the same as of SYMBICORT TURBOHALER® and is safe and effective to treat children, teenagers, and adults with asthma.EUCTR2013-000081-11-ITTeva Branded Pharmaceutical Products R&D, Inc.600